Effects of metronidazole analogues on Giardia lamblia: experimental infection and cell organization.

Diagn Microbiol Infect Dis

Depto. Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627, Belo Horizonte, MG, Brazil.

Published: February 2013

The chemotherapeutic agents used for the treatment of giardiasis are often associated with adverse side effects and are refractory cases, due to the development of resistant parasites. Therefore the search for new drugs is required. We have previously reported the giardicidal effects of metronidazole (MTZ) and its analogues (MTZ-Ms, MTZ-Br, MTZ-N(3), and MTZ-I) on the trophozoites of Giardia lamblia. Now we evaluated the activity of some giardicidal MTZ analogues in experimental infections in gerbils and its effects on the morphology and ultrastructural organization of Giardia. The giardicidal activity in experimental infections showed ED(50) values significantly lower for MTZ-I and MTZ-Br when compared to MTZ. Transmission electron microscopy was employed to approach the mechanism(s) of action of MTZ analogues upon the protozoan. MTZ analogues were more active than MTZ in changing significantly the morphology and ultrastructure of the parasite. The analogues affected parasite cell vesicle trafficking, autophagy, and triggered differentiation into cysts. These results coupled with the excellent giardicidal activity and lower toxicity demonstrate that these nitroimidazole derivates may be important therapeutic alternatives for combating giardiasis. In addition, our results suggest a therapeutic advantage in obtaining synthetic metronidazole analogues for screening of activities against other infectious agents.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2012.11.001DOI Listing

Publication Analysis

Top Keywords

mtz analogues
16
effects metronidazole
8
metronidazole analogues
8
giardia lamblia
8
experimental infections
8
giardicidal activity
8
analogues
7
mtz
6
effects
4
analogues giardia
4

Similar Publications

3D printed reservoir-like vaginal rings for antibiotic delivery.

Int J Pharm

January 2025

Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via Giuseppe Colombo 71, 20133, Milano, Italy.

Targeting the development of 3D printed reservoir-like vaginal rings (VRs) intended to fulfill the needs of precision medicine, prototypes ensuring prolonged release of metronidazole (MTZ) were preliminary manufactured and tested. Indeed, this drug represents the first-line therapy against bacterial vaginosis, which would especially benefit from convenient as well as easy dose adjustment and from more than 48 h continuous release, thus avoiding barely tolerated and repeated administrations. Starting from a soft thermoplastic elastomer (TPE), hollow ring structures were successfully printed at 190 °C and then extemporaneously filled with drug-loaded, in-situ-crosslinking hydrogel formulations based on alginate (ALG).

View Article and Find Full Text PDF

Giardia duodenalis flavohemoglobin is a target of 5-nitroheterocycle and benzimidazole compounds acting as enzymatic inhibitors or subversive substrates.

Free Radic Biol Med

February 2025

Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Mexico City, Mexico. Electronic address:

Giardia duodenalis causes giardiasis in humans, companion, livestock and wild animals. Control of infection involves drugs as benzimidazoles (e.g.

View Article and Find Full Text PDF

Effects of cardanol-based phospholipid analogs on Trichomonas vaginalis.

Exp Parasitol

November 2024

Universidade Do Grande Rio, Duque de Caxias, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Centro de Pesquisa Em Medicina de Precisão, Universidade Federal Do Rio de Janeiro, 21941-901, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil. Electronic address:

Article Synopsis
  • * The common treatment, Metronidazole (MTZ), has limitations due to toxicity and rising resistance, highlighting the need for new treatment options.
  • * The study identifies two novel compounds, LDT117 and LDT134, which effectively combat T. vaginalis with low toxicity to human cells, showing promising results that warrant further animal testing for potential use in treating human infections.
View Article and Find Full Text PDF

Discovery and evolution of berberine analogues as anti-Helicobacter pylori agents with multi-target mechanisms.

Bioorg Chem

October 2024

Dongguan Maternal and Child Health Care Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Dongguan, Guangdong, 523000, China; Department of Critical Medicine, Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518020, China; State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address:

Article Synopsis
  • Thirty new protoberberine derivatives were synthesized to test their effectiveness against Helicobacter pylori, focusing on a compound called 2,3,10-trimethoxy-9-p-methylbenzylaminoprotopalmatine chloride as the lead.
  • The most promising derivative, 7c, showed strong anti-bacterial activity against both metronidazole-resistant and susceptible strains, with minimal toxicity and stability in testing conditions.
  • The compound 7c is believed to work by targeting HP urease and affecting bacterial membrane permeability, making it a valuable candidate for further development as a treatment for H. pylori infections.
View Article and Find Full Text PDF

Purpose: Pan-retinal photocoagulation (PRP) is the mainstay of treatment for proliferative diabetic retinopathy (PDR), reducing the risk of severe vision loss. Pain poses a potential obstacle to effective laser delivery and patient compliance. Therefore, implementing pain relief strategies can enhance both treatment efficacy and patient comfort.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!